25 May 2013
Keywords: medimmune, opens, new, unit, uk, anglo-swedish, drug
Article | 27 October 2008
MedImmune, a unit of Anglo-Swedish drug major AstraZeneca, has opened a new, biologics R&D facility in Cambridge, UK. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 October 2008
24 May 2013
© 2013 thepharmaletter.com